National Cooperative Crohn's Disease Study: adverse reactions to study drugs.

[1]  H. Mekhjian,et al.  Clinical features and natural history of Crohn's disease. , 1979, Gastroenterology.

[2]  R. Sturdevant,et al.  Azathioprine-related pancreatitis in patients with Crohn's disease. , 1979, Gastroenterology.

[3]  D. Winship,et al.  National Cooperative Crohn's Disease Study: study design and conduct of the study. , 1979, Gastroenterology.

[4]  R. Summers,et al.  National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.

[5]  O. Bonnevie,et al.  The Long-term Prophylactic Effect of Salazosulfapyridine (SalazopyrinR) in Primarily Resected Patients with Crohn's Disease , 1978 .

[6]  W. Bernhard,et al.  Frank W. Konzelmann, M.D. (1894-1977). , 1978, American Journal of Clinical Pathology.

[7]  D. Present,et al.  Immunotherapy in inflammatory bowel disease. , 1978, The Medical clinics of North America.

[8]  J. Lennard-jones,et al.  Sulphasalazine in asymptomatic Crohn's disease. A multicentre trial. , 1977, Gut.

[9]  D. Sachar,et al.  THE EXTRA-INTESTINAL COMPLICATIONS OF CROHN'S DISEASE AND ULCERATIVE COLITIS: A STUDY OF 700 PATIENTS , 1976, Medicine.

[10]  D. Cave,et al.  PLACE OF AZATHIOPRINE FOR CROHN'S DISEASE , 1976, The Lancet.

[11]  D. Jewell,et al.  Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. , 1976, Clinical and experimental immunology.

[12]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[13]  A. Fauci,et al.  Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.

[14]  B. Danielson,et al.  Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine. , 1975, Gastroenterology.

[15]  D. Jewell,et al.  Azathioprine in Ulcerative Colitis: Final Report on Controlled Therapeutic Trial , 1974, British medical journal.

[16]  R. Rault,et al.  OBSERVATIONS ON THE INCIDENCE AND CAUSE OF MACROCYTOSIS IN PATIENTS ON AZATHIOPRINE THERAPY FOLLOWING RENAL TRANSPLANTATION , 1974, Transplantation.

[17]  H. Spiro,et al.  Treatment of Crohn's disease with azathioprine: a controlled evaluation. , 1974, Gastroenterology.

[18]  J. McManus,et al.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. , 1973, The New England journal of medicine.

[19]  T. Starzl,et al.  Malignant tumors arising de novo in immunosuppressed organ transplant recipients. , 1972 .

[20]  Lennard-Jones Je.  Azathioprine in the treatment of Crohn's disease. , 1972 .

[21]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[22]  O. Fausa,et al.  Azathioprine (Imurel) therapy in Crohn's disease. , 2009, Acta medica Scandinavica.

[23]  D. Bainton,et al.  Controlled trial of azathioprine in Crohn's disease. , 1971, Lancet.

[24]  J. Balint,et al.  Granulomatous bowel (Crohn's disease. A retrospective study of the course and treatment. , 1971, Archives of internal medicine.

[25]  A. Dawson,et al.  Controlled trial of azathioprine in Crohn's disease. , 1971, Lancet.

[26]  A. Kark,et al.  Regional Enteritis and Entero‐Colitis: A Study of 74 Patients over 15 Years , 1969, Annals of surgery.

[27]  F. Jones,et al.  Dangers of Immunosuppressive Drugs in Ulcerative Colitis , 1966, British medical journal.

[28]  R. Carpenter,et al.  Controlled trial of sulphasalazine in the treatment of ulcerative colitis , 1964, Gut.

[29]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .